Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLAB: Closed-Loop Insulin in Abdominal Surgery
NCT05392452Completed
- Start
- Aug 2022
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
Randomised, open-label trial. Primary endpoint: Proportion of time spent in the target glucose range (5.6 to 10.0 mmol/L) up to 20 days. Started Aug 2022; status: completed.
Beyond the preview
Go deeper on NCT05392452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05392452.